INTCHAINS GROUP LTD-ADR (ICG) Stock Fundamental Analysis

NASDAQ:ICG • US45828E1047

1.49 USD
+0.04 (+2.76%)
Last: Feb 18, 2026, 02:31 PM
Fundamental Rating

5

Taking everything into account, ICG scores 5 out of 10 in our fundamental rating. ICG was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. ICG has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, ICG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ICG had positive earnings in the past year.
  • Of the past 5 years ICG 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: ICG reported negative operating cash flow in multiple years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

  • The Return On Assets of ICG (7.96%) is better than 76.11% of its industry peers.
  • ICG has a better Return On Equity (8.25%) than 67.26% of its industry peers.
Industry RankSector Rank
ROA 7.96%
ROE 8.25%
ROIC N/A
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • ICG has a better Profit Margin (35.25%) than 93.81% of its industry peers.
  • In the last couple of years the Profit Margin of ICG has declined.
  • ICG's Operating Margin has declined in the last couple of years.
  • ICG's Gross Margin of 36.86% is on the low side compared to the rest of the industry. ICG is outperformed by 60.18% of its industry peers.
  • ICG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 35.25%
GM 36.86%
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

  • ICG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ICG has about the same amount of shares outstanding.
  • There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • ICG has an Altman-Z score of 10.96. This indicates that ICG is financially healthy and has little risk of bankruptcy at the moment.
  • ICG's Altman-Z score of 10.96 is fine compared to the rest of the industry. ICG outperforms 76.11% of its industry peers.
  • There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.96
ROIC/WACCN/A
WACC9.62%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 16.57 indicates that ICG has no problem at all paying its short term obligations.
  • ICG has a Current ratio of 16.57. This is amongst the best in the industry. ICG outperforms 98.23% of its industry peers.
  • A Quick Ratio of 13.32 indicates that ICG has no problem at all paying its short term obligations.
  • The Quick ratio of ICG (13.32) is better than 98.23% of its industry peers.
Industry RankSector Rank
Current Ratio 16.58
Quick Ratio 13.33
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 90.00% over the past year.
  • Measured over the past years, ICG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -51.46% on average per year.
  • Looking at the last year, ICG shows a small growth in Revenue. The Revenue has grown by 6.47% in the last year.
  • ICG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.10% yearly.
EPS 1Y (TTM)90%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%350%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%-85.05%

3.2 Future

  • ICG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -11.54% yearly.
  • ICG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.95% yearly.
EPS Next Y-22.74%
EPS Next 2Y-11.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.79%
Revenue Next 2Y11.95%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

1

4. Valuation

4.1 Price/Earnings Ratio

  • ICG is valuated quite expensively with a Price/Earnings ratio of 49.67.
  • 66.37% of the companies in the same industry are more expensive than ICG, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.16, ICG is valued quite expensively.
  • ICG is valuated quite expensively with a Price/Forward Earnings ratio of 101.20.
  • Based on the Price/Forward Earnings ratio, ICG is valued a bit more expensive than 62.83% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.10. ICG is valued rather expensively when compared to this.
Industry RankSector Rank
PE 49.67
Fwd PE 101.2
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as ICG's earnings are expected to decrease with -11.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for ICG!.
Industry RankSector Rank
Dividend Yield 0%

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (2/18/2026, 2:31:34 PM)

1.49

+0.04 (+2.76%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners0.22%
Inst Owner Change91.44%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap89.95M
Revenue(TTM)258.15M
Net Income(TTM)91.00M
Analysts80
Price Target3.57 (139.6%)
Short Float %1.04%
Short Ratio2.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)774.98%
Min EPS beat(2)42.23%
Max EPS beat(2)1507.72%
EPS beat(4)2
Avg EPS beat(4)338.39%
Min EPS beat(4)-136%
Max EPS beat(4)1507.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-71.04%
Min Revenue beat(2)-83%
Max Revenue beat(2)-59.09%
Revenue beat(4)1
Avg Revenue beat(4)-42.18%
Min Revenue beat(4)-83%
Max Revenue beat(4)9.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-30%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.57%
EPS NY rev (1m)0%
EPS NY rev (3m)1272.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-41.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.43%
Valuation
Industry RankSector Rank
PE 49.67
Fwd PE 101.2
P/S 2.41
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)0.03
EY2.01%
EPS(NY)0.01
Fwd EY0.99%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.62
BVpS2.64
TBVpS2.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.34
Profitability
Industry RankSector Rank
ROA 7.96%
ROE 8.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.25%
GM 36.86%
FCFM N/A
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
F-ScoreN/A
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.58
Quick Ratio 13.33
Altman-Z 10.96
F-ScoreN/A
WACC9.62%
ROIC/WACCN/A
Cap/Depr(3y)583.15%
Cap/Depr(5y)424.89%
Cap/Sales(3y)21.73%
Cap/Sales(5y)13.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%350%
EPS Next Y-22.74%
EPS Next 2Y-11.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.47%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%-85.05%
Revenue Next Year-28.79%
Revenue Next 2Y11.95%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-192.5%
EBIT growth 3Y-62.17%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-170.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2829.94%
OCF growth 3YN/A
OCF growth 5YN/A

INTCHAINS GROUP LTD-ADR / ICG FAQ

Can you provide the ChartMill fundamental rating for INTCHAINS GROUP LTD-ADR?

ChartMill assigns a fundamental rating of 5 / 10 to ICG.


What is the valuation status for ICG stock?

ChartMill assigns a valuation rating of 1 / 10 to INTCHAINS GROUP LTD-ADR (ICG). This can be considered as Overvalued.


What is the profitability of ICG stock?

INTCHAINS GROUP LTD-ADR (ICG) has a profitability rating of 3 / 10.


How financially healthy is INTCHAINS GROUP LTD-ADR?

The financial health rating of INTCHAINS GROUP LTD-ADR (ICG) is 8 / 10.